TY - JOUR
AU - Saki, Najmaldin
AB - Targeting the PI3K/Akt/mTOR pathway may have pro-apoptotic and antiproliferative effects on hematological malignancies. Furthermore, modulation of miRNA can be used as a novel therapeutic approach to regulate the PI3K/Akt/mTOR pathway. However, both aspects require further clinical studies.
TI - Targeting PI3K/AKT/mTOR network for treatment of leukemia
JF - Cellular and Molecular Life Sciences
DO - 10.1007/s00018-015-1867-5
DA - 2015-02-25
UR - https://www.deepdyve.com/lp/springer-journals/targeting-pi3k-akt-mtor-network-for-treatment-of-leukemia-Nv6Z9AoBXt
SP - 2337
EP - 2347
VL - 72
IS - 12
DP - DeepDyve
ER -